Aggressive and relatively common lymphomas called diffuse large B cell lymphomas have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from Cornell researchers.
Sarah Besky says causes for ‘mystery illnesses,’ especially in marginalized areas, are hard to identify given the multiple risk factors that are a part of domestic life in these regions.
Several Cornellians – appointed by Gov. Kathy Hochul – will explore how thewarming environment will affect New York’s communities, ecosystems and economy in the new Climate Impacts Assessment project.
Researchers at the College of Veterinary Medicine plan to develop an enzyme-based technology into a range of diagnostic tests that can be performed anywhere using a handheld device.
Alan Mathios, who studies the effectiveness of proposed cigarette package warning labels on smoking onset and quit behavior, reacts to the announcement that investigators in 39 states will look into Juul Labs' youth marketing practices.
Following a sweeping effort in 2019 to address clinical care team well-being across Weill Cornell Medicine, physicians note a reduction in stress and feelings of burnout compared to previous surveys, according to a new report from the institution.
An alternative statistical method honed and advanced by Cornell researchers can make clinical trials more reliable and trustworthy while also helping to remedy what has been called a “replicability crisis” in the scientific community.
Scientists at the College of Veterinary Medicine developed a new technology for studying viruses directly in their host cells, opening the door to finding a functional cure for HIV – and a possible tool in the fight against COVID-19.
Anti-Mullerian hormone, traditionally thought of as a passive byproduct of polycystic ovary syndrome, may actually play an active role in the disorder, according to new research.
Cornell researchers’ concept for a mobile phone-based system to detect infectious diseases and nutritional deficiencies in saliva was awarded a $100,000 NIH Technology Accelerator Challenge prize.
